Biological age: what it is and how to measure it

Biological age is an estimate of how your body is aging compared with your chronological age. It does not count birthdays. It looks at systems: metabolism, inflammation, body composition, cardiorespiratory fitness, immune function, sleep and molecular marks such as DNA methylation.

The idea is easy to understand because we all see it. Two people can be 55 on paper and live in very different bodies. One has high blood pressure, visceral fat, poor sleep, low strength and rising glucose. Another trains, keeps muscle, sleeps well and has low inflammatory markers. Chronological age is the same. Biology is not.

The problem is that the market has turned biological age into a seductive number: “you are 42 biologically”, “you reversed five years”, “your clock is slower”. Some tests are scientifically useful. Others are marketing with a lab report. The useful question is not only what number appears, but what the test measures, what it misses and what decision changes after seeing it.

Chronological age vs biological age

Chronological age measures time. Biological age tries to estimate accumulated damage, functional reserve and future risk. It is not a hidden birthday inside your body. It is a model. Like every model, it depends on the data it uses.

A blood-based model can capture inflammation, liver function, glucose control, lipids and kidney function. An epigenetic clock can capture DNA methylation patterns. A functional test can measure grip strength, balance or VO₂max (mL/kg/min). Each layer sees a different part of the aging process.

That is why “what is my biological age?” is an incomplete question. The better question is: which layer of my aging am I measuring, and what will I do differently because of the result?

How biological age is measured

There are three main families of tests. The first uses clinical biomarkers: albumin, creatinine, glucose, C-reactive protein, lymphocytes, blood pressure, HbA1c, ApoB, body composition and physical capacity. The second uses molecular data, especially DNA methylation. The third combines several layers: blood work, function, habits, imaging, omics and clinical risk.

Test type	What it measures	Main advantage	Main limit
Clinical biomarkers	Inflammation, metabolism, organs, blood	Actionable and accessible	They do not capture the whole biology of aging
Epigenetic clocks	DNA methylation	Useful in research and follow-up	Clinical interpretation is still developing
Functional tests	Strength, VO₂max, balance, mobility	Connected to real autonomy	Depend on effort and protocol
Integrated models	Several layers at once	Better medical context	More complex and not always comparable

A 2017 review by Jylhävä, Pedersen and Hägg in EBioMedicine summarized the field well: biological age predictors include epigenetic clocks, telomeres, transcriptomics, proteomics, metabolomics and composite models. Their conclusion still holds: epigenetic clocks are promising, but their real value depends on longitudinal validation and clinical context.

Multimodal approaches move in that direction. Ahadi et al. followed 106 people with longitudinal multi-omic profiling and described “ageotypes”, personal aging patterns linked to metabolic, immune, hepatic and renal pathways (Nature Medicine, 2020, PMID: 31932806). Kudryashova et al. reviewed the shift from isolated functional tests toward integrated multi-omics biomarkers (Proteomics, 2020, PMID: 32084299). The practical lesson is simple: context beats a lonely number.

Epigenetic clocks: Horvath, PhenoAge, GrimAge and DunedinPACE

Epigenetic clocks analyze DNA methylation patterns. Methylation changes with age and with exposures such as smoking, inflammation, obesity, exercise, sleep and disease. In 2013, Steve Horvath published a pan-tissue clock using 353 CpG sites and achieved a very high correlation with chronological age. It was a major step for aging biology.

Later clocks became more risk-oriented. PhenoAge, published by Levine and colleagues in 2018, combined clinical information and methylation to predict mortality, cancer, healthspan, physical function and Alzheimer's disease better than first-generation clocks. GrimAge, published by Lu et al. in 2019, integrated signals related to plasma proteins and smoking; in large validations, it strongly predicted time to death, coronary heart disease and cancer.

DunedinPACE, published in eLife in 2022, changed the framing. Instead of estimating how many biological years you have accumulated, it estimates the current pace of aging. That makes it interesting for intervention tracking, although it still should not be treated as a sentence.

Which biological age test makes sense?

If you have never measured anything, starting with an expensive epigenetic test is often the wrong sequence. First, it usually makes sense to know the basics: blood pressure, HbA1c, fasting insulin, ApoB, triglycerides, hsCRP, liver and kidney function, vitamin D when relevant, body composition, strength and cardiorespiratory fitness. In advanced cardiovascular prevention, high lipoprotein(a) can also change decisions because it reveals inherited risk that a basic cholesterol panel may miss. These longevity biomarkers sound less exotic, but they change decisions more often.

VO₂max (mL/kg/min) is a good example. In a 2018 JAMA Network Open study with 122,007 people, high cardiorespiratory fitness was linked to up to 5-fold lower mortality risk compared with low fitness (Mandsager et al., PMID: 30646252). That is not a fashionable number. It is a risk signal you can train.

An epigenetic clock may make sense once a baseline assessment exists, when you want a global follow-up marker, or when you are inside a serious intervention program. It makes little sense if it will be read like molecular astrology or if the result will not change anything.

Biological age should not be measured every month. Many real changes take months or years. If you change diet, sleep, training and visceral fat over 12 weeks, glucose, blood pressure, HRV, VO₂max or inflammation may move first. DNA methylation may take longer, and it also has technical variation.

Limits of commercial biological age tests

Three limits matter. First, different tests can give different ages in the same person because they use different algorithms and tissues. Saliva, blood and cheek cells are not identical. Second, a difference of a few years may sit inside technical or biological variation. Third, many commercial reports mix real science with generic recommendations.

This does not mean epigenetic clocks are useless. It means precision matters. A biomarker is not valuable because it sounds advanced; it is valuable when it helps a clinician make a better decision.

If your report says you are five years older biologically but does not review sleep, visceral fat, strength, ApoB, inflammation or glucose, the interpretation is incomplete. A number without context can create anxiety instead of health.

What actually changes biological age?

There is no single intervention that reliably “lowers biological age” for everyone. What we do know is that several aging accelerators can improve: insulin resistance, hypertension, chronic inflammation, sedentary behavior, excess visceral fat, low muscle mass, smoking, alcohol excess, sleep apnea and poor recovery.

The most reliable results usually come from the least glamorous work: resistance training, an aerobic base, loss of visceral fat when needed, Mediterranean-style nutrition with enough protein, stable sleep, blood pressure control and lower toxic exposure. Advanced treatments can have a place, but they do not compensate for a broken base.

In the framework of the hallmarks of aging, these interventions act on several pathways at once: inflammation, mitochondrial dysfunction, cellular senescence, nutrient sensing and intercellular communication. That is why they matter for healthspan.

How Progevita interprets biological age

At Progevita, we do not use biological age as a trophy. We use it as a clinical conversation. A person may arrive wanting to know their “real age”, but what they need is to understand which systems are accelerating risk and what should happen over the next 12 months.

In programs such as Optimization or Inflammaging, an integrated assessment can combine advanced blood work, body composition, functional testing, inflammation, sleep, clinical history and, in selected cases, epigenetic clocks. With that map, the medical team can decide whether to prioritize nutrition, strength, VO₂max, hormone management, NAD+, ozone therapy, plasmapheresis or other protocols.

The aim is not to leave with a pretty number. The aim is to leave with a plan: measure, intervene, re-measure what matters and adjust. That is the difference between biological curiosity and preventive medicine.

Common mistakes when reading biological age

The first mistake is comparing your result with someone else's. If the test, tissue, laboratory or algorithm changes, the comparison loses value. It is more useful to compare your own trajectory using the same method and enough time between measurements.

The second mistake is treating a small difference as a verdict. Two or three years can sound dramatic in a report, but they may reflect technical variation, recent inflammation, sleep, training, medication or the sample itself. Before making decisions, the result has to match the rest of the clinical picture.

The third mistake is looking for an “anti-age” intervention before correcting the obvious. If ApoB, blood pressure, HbA1c, visceral fat or strength are poor, that is the priority. An epigenetic clock can motivate, but it should not distract from factors we already know change real outcomes.

The fourth mistake is testing without a question. A good test answers something specific: am I aging faster than expected, did my intervention work, which system limits my healthspan, what should I prioritize this year? Without a question, the result becomes expensive entertainment.

Frequently asked questions about biological age

What is biological age?

Biological age is an estimate of how aged your body is compared with your chronological age. It can be calculated using clinical biomarkers, functional tests, epigenetic clocks or combined models. It is not an exact age and it is not an individual death prediction.

What is the best biological age test?

It depends on the goal. For clinical decisions, basic and functional biomarkers are often the best starting point. For global follow-up or research, clocks such as GrimAge, PhenoAge or DunedinPACE can add information when interpreted with medical context.

Are epigenetic clocks reliable?

They are powerful scientific tools, but not perfect. They predict age, risk or pace of aging depending on the algorithm. Different tests can produce different results. Interpretation should consider tissue, method, variation and clinical status.

Can I lower my biological age?

You can improve many markers linked to aging: glucose, blood pressure, visceral fat, strength, VO₂max, inflammation and sleep. Some studies report changes in epigenetic clocks after interventions, but promising to “reverse X years” is too strong.

How often should I measure biological age?

Clinical biomarkers can be repeated every 3-12 months depending on risk and intervention. Epigenetic clocks usually make more sense with longer spacing and only when the result will change decisions. Testing too soon creates noise.

What should I do if my biological age is high?

Do not panic. Review which test was used, its margin of error and which concrete biomarkers are altered. Then prioritize what can be changed: sleep, strength, aerobic fitness, visceral fat, inflammation, metabolism, blood pressure and habits. The number only helps if it leads to a plan.

References

1. Horvath S. “DNA methylation age of human tissues and cell types.” Genome Biology. 2013;14:R115. PMID: 24138928.
2. Levine ME, Lu AT, Quach A, et al. “An epigenetic biomarker of aging for lifespan and healthspan.” Aging. 2018;10(4):573-591. PMID: 29676998.
3. Lu AT, Quach A, Wilson JG, et al. “DNA methylation GrimAge strongly predicts lifespan and healthspan.” Aging. 2019;11(2):303-327. PMID: 30669119.
4. Belsky DW, Caspi A, Corcoran DL, et al. “DunedinPACE, a DNA methylation biomarker of the pace of aging.” eLife. 2022;11:e73420. PMID: 35029144.
5. Jylhävä J, Pedersen NL, Hägg S. “Biological Age Predictors.” EBioMedicine. 2017;21:29-36. PMID: 28396265.
6. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. “Hallmarks of aging: An expanding universe.” Cell. 2023;186(2):243-278. PMID: 36599349.
7. Mandsager K, Harb S, Cremer P, et al. “Association of cardiorespiratory fitness with long-term mortality among adults undergoing exercise treadmill testing.” JAMA Network Open. 2018;1(6):e183605. PMID: 30646252.
8. Ahadi S, Zhou W, Schüssler-Fiorenza Rose SM, et al. “Personal aging markers and ageotypes revealed by deep longitudinal profiling.” Nature Medicine. 2020;26:83-90. PMID: 31932806.
9. Kudryashova KS, Burka K, Kulaga AY, et al. “Aging Biomarkers: From Functional Tests to Multi-Omics Approaches.” Proteomics. 2020;20:e1900408. PMID: 32084299.

This article is informational and does not replace individual medical assessment. Biological age tests should be interpreted together with clinical history, biomarkers and real goals.

Want to measure biological age with medical context, not as a lonely number? Request an integrated Progevita assessment.